NEA Management Company »

Oric Pharmaceuticals shares owned by NEA Management Company

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by NEA Management Company from 13F filings

Historical chart of NEA Management Company investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by NEA Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by NEA Management Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $21M 1.5M 13.75

More positions owned by NEA Management Company

Arcellx Common Stock (ACLX)
Crispr Therapeutics Namen Akt (CRSP)
Rhythm Pharmaceuticals (RYTM)
Savara (SVRA)
Coursera (COUR)
Korro Bio (KRRO)
Verona Pharma Sponsered Ads (VRNA)
Monte Rosa Therapeutics (GLUE)
Nextnav Common Stock (NN)
CVRX (CVRX)
Geron Corporation (GERN)
Trevi Therapeutics (TRVI)
Nkarta (NKTX)
Celcuity (CELC)
Adaptimmune Therapeutics Sponds Adr (ADAP)

View all positions for NEA Management Company

Top funds holding Oric Pharmaceuticals

Nextech Invest
FMR
VR Adviser
Frazier Life Sciences Management
Viking Global Investors
Column Group
EcoR1 Capital
BlackRock
Vanguard Group
Commodore Capital
Boxer Capital
T. Rowe Price Associates
Arrowpoint Asset Management
NEA Management Company
First Turn Management

View all funds holding Oric Pharmaceuticals